Erin McEvoy

At the Cannabis Science Conference, Antonio Timoteo Jr., PhD, presented research on cannabis cultivation practices and optimizing terpene content.

In the Cultivation Track at Cannabis Science Conference, Bernie Lorenz, Chief Science Officer of ProKure Solutions, discussed the intriguing topic of the effects of COVID on cannabis testing methods.

In the General Session of the Cannabis Science Conference, Scheril Murray Powell, Esq. and John Calloway Jr. discussed the many ways equity ties into science in the cannabis industry.

Patrick Bird, Senior Manager of Scientific Affairs at bioMérieux, presented “Innovative Method Development to Meet the Needs for the Cannabis Industry" on the first day of Cannabis Science Conference in the Analytical Track.

As the keynote speaker for Cannabis Science Conference Spring 2024, Jamila Owens-Todd discussed the various ways to approach plant medicine and manufacturing.

Multiple sources have reported that the US Drug Enforcement Administration will move to reclassify marijuana from Schedule I to Schedule III, effectively recognizing medical uses of cannabis and its reduced potential for abuse compared with other drugs.

Here, Darwin Millard, Technical Director of CSQ, discusses the present and potential future of cannabis standards and regulations.

In this interview, Darwin Millard shares what attendees will experience in the two ASTM Subcommittee meetings he will be guiding.

In this interview, Jimmy Farrell, Standards Development Manager at ASTM International, explains the important role ASTM plays in safety and quality of the global cannabis industry.

In this interview, Jimmy Farrell explains more on this opportunity to shape standards and methods in the global cannabis industry.

In the second installment in this webinar series, Dr. Marion McNabb and Dr. Peter Grinspoon discuss implementation of cannabis as a harm reduction agent from a clinical perspective.

Kentucky Governor signs HB 829, and introduces lottery for dispensary applications.

In recognizing the 4/20 holiday, here is a selection of regulatory updates and commentary in the cannabis industry this year so far.

The cannabis business license application system has raised concerns with several stakeholders.

Hear what Patrick Bird says about optimizing method development, good manufacturing practices, and cannabis genomics.

Learn more from Patrick Bird about the hands-on microbiology workshop at the upcoming Cannabis Science Conference Spring 2024.

Recreational cannabis legalization in New Hampshire encounters another setback.

The plant-based material hempcrete is slowly being used in more construction projects in the US, highlighting its versatility.

A collection of our most recent webinar coverage discussing medical research and testing methods.

This month’s Healer webinar provided a deep dive into six studies on cannabis for various conditions.

Keynote speaker Jamila Owens-Todd shares her perspectives on cannabis from medical and science viewpoints.

In the first installment of a three-part webinar series, Dr. Marion McNabb and Dr. Peter Grinspoon share their insights on cannabis as a harm reduction option.

Several efforts have been made to limit the prevalence of intoxicating hemp products.

The contrast between cannabis for medical and recreational use in Canada since their respective legalizations.

Hear exclusive details about the pre-conference workshop for nurses and the latest on cannabis nursing from two of the presenters.

One step forward, two steps back: updates on cannabis legal movements in three different states.

Several recent survey results, including from the Pew Research Center, show an increase in support and interest in cannabis in the US.

This month’s webinar covered the many facets of fit for purpose testing of cannabis products.

Analytical Track Program Chair Julie Kowalski discusses details from the four preconference workshops.

As the Chair for the Analytical Track and the Director of Technical Programming, Julie Kowalski gives an inside look into the conference.